Case-control study examining brain volumes in schizophrenia and bipolar disorders, revealing specific limbic alterations.
BACKGROUND: Schizophrenia spectrum disorders (SSD) and bipolar disorders (BD) are severe mental disorders linked to brain alterations in the limbic system. Small, anatomically complex structures remain unexplored in morphological studies of these disorders. We examined case-control differences in MRI-derived brain volumes of the fornix, nucleus accumbens, basal forebrain, septal nuclei, hypothalamus, and mammillary bodies, and their associations with clinical characteristics, sex, and cognition. STUDY DESIGN: , sex, and intracranial volume, assessed for volumetric case-control differences and associations with clinical variables. STUDY RESULTS: We observed smaller right nucleus accumbens volumes in SSD (Cohen's d = -0.19, p = 0.004) and smaller right fornix volumes (p = 0.008) in SSD (d = -0.16) and BD (d = -0.12) compared to HC, found specifically in schizophrenia and bipolar I disorder subgroups. Additionally, SSD patients using antipsychotic medication (AP) had smaller bilateral basal forebrain volumes than non-users (left: p = 0.003, d = -0.27; right: p = 0.005, d = -0.26). Smaller basal forebrain volumes were associated with higher anticholinergic burden of AP medication (p = 0.01, r = -0.11) and attentional deficits (p = 0.009, r = 0.19) in secondary analyses, with the latter emerging only without intracranial volume adjustment. CONCLUSION: The findings highlight region-specific smaller volumes in subcortical limbic structures in SSD and BD relative to healthy controls. Observed basal forebrain differences suggest a potential impact of AP use, warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Blakstad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: